Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

A ctDNA-guided Phase II Trial of Osimertinib in Combination With Sacituzumab Tirumotecan in EGFR-mutated Advanced NSCLC Patients With Positive ctDNA After lead-in Osimertinib Monotherapy

NCT07375316

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University Guangzhou, Guangdong, China
  • Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences Meizhou, Guangdong, China
  • The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China
  • Peking University Shenzhen Hospital Shenzhen, Guangdong, China
View Trial Details
Recruiting

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

NCT05431270

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Sarah Cannon Research Institute University of Oklahoma Oklahoma City, Oklahoma, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

NCT06284317

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
View all 42 locations
View Trial Details

Related conditions